The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive ...
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...
The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.
The Federal Trade Commission (FTC) has filed a legal complaint accusing the 3 largest pharmacy benefit managers (PBMs) in the ...
The FTC sued UnitedHealth Group’s Optum unit, CVS Caremark and Cigna’s Express Scripts for allegedly steering diabetes ...
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at ...
The Federal Trade Commission said the three companies' practices have artificially inflated list prices for insulin.
The Federal Trade Commission filed an action against the three largest prescription drug benefit managers or PBMs— CVS Health's ...
The FTC said CVS Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx profit at the expense of patients forced to ...